Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-19-032141

Options or other derivatives

  • CEO, President and Secretary acquired 187,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mehta Vimal CEO, President and Secretary 2019-05-23 Grant or award · Stock Option (Right to Buy) +187,700 187,700 D: show line 1 in the form
Loading xslF345X03/a4.xml…